Ignite Creation Date:
2024-05-06 @ 3:16 AM
Last Modification Date:
2024-10-26 @ 11:31 AM
Study NCT ID:
NCT02248571
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2014-08-28
Brief Title:
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Sponsor:
iOMEDICO AG
Organization:
iOMEDICO AG
Organization Data
Organization:
iOMEDICO AG
Class:
INDUSTRY
Study ID:
iOM-12293
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
iOMEDICO AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Arbeitsgemeinschaft fur Internistische Onkologie | OTHER |
| Novartis Pharmaceuticals | INDUSTRY |